Personalized Surgical Decision-Making Model for Clinical Stage IA Pure-Solid Non-small Cell Lung Cancer.
[BACKGROUND] Making an optimal surgical procedure decision (lobar or sublobar resections) remains challenging for some early-stage non-small cell lung cancer (NSCLC).
- p-value P = 0.004
- p-value P = 0.002
APA
Yan H, Niimi T, et al. (2026). Personalized Surgical Decision-Making Model for Clinical Stage IA Pure-Solid Non-small Cell Lung Cancer.. Annals of surgical oncology, 33(2), 935-945. https://doi.org/10.1245/s10434-025-18610-0
MLA
Yan H, et al.. "Personalized Surgical Decision-Making Model for Clinical Stage IA Pure-Solid Non-small Cell Lung Cancer.." Annals of surgical oncology, vol. 33, no. 2, 2026, pp. 935-945.
PMID
41120775
Abstract
[BACKGROUND] Making an optimal surgical procedure decision (lobar or sublobar resections) remains challenging for some early-stage non-small cell lung cancer (NSCLC). This study aimed to evaluate the feasibility of developing a personalized model exclusively for surgical decision-making in early-stage NSCLC.
[METHODS] Propensity score matching was performed to diminish the influence of the surgeon's surgical procedure decision. Clinical and radiomic covariates were modified by the surgical procedure to reflect the interaction between the surgical procedure and covariates. The least absolute shrinkage and selection operator, Cox regression, was used for model development. Patients were divided into positive-score and negative-score groups based on a predicted score threshold of 0.
[RESULTS] After matching, 369 patients with clinical stage IA pure-solid NSCLC were included. Of the 248 modified covariates, 14 were selected, including four clinical and ten radiomic covariates. The surgical decision-making model generated a score for each patient (mean -0.43; standard deviation 0.97). In the positive-score group, sublobar resection was associated with significantly worse recurrence-free survival (RFS) than lobar resection (hazard ratio [HR], 4.15; 95% confidence interval [CI], 1.47, 11.7; P = 0.004). In contrast, sublobar resection was superior to lobar resection in terms of RFS (HR, 0.4; 95% CI, 0.22, 0.73; P = 0.002) for the negative-score group patients. For overall survival, lobar resection was favored in the positive-score group (P < 0.001), while sublobar resection was favored in the negative-score group (P < 0.04).
[CONCLUSIONS] The personalized surgical decision-making model potentially helps to decide the optimal surgical procedure for early-stage NSCLC.
[METHODS] Propensity score matching was performed to diminish the influence of the surgeon's surgical procedure decision. Clinical and radiomic covariates were modified by the surgical procedure to reflect the interaction between the surgical procedure and covariates. The least absolute shrinkage and selection operator, Cox regression, was used for model development. Patients were divided into positive-score and negative-score groups based on a predicted score threshold of 0.
[RESULTS] After matching, 369 patients with clinical stage IA pure-solid NSCLC were included. Of the 248 modified covariates, 14 were selected, including four clinical and ten radiomic covariates. The surgical decision-making model generated a score for each patient (mean -0.43; standard deviation 0.97). In the positive-score group, sublobar resection was associated with significantly worse recurrence-free survival (RFS) than lobar resection (hazard ratio [HR], 4.15; 95% confidence interval [CI], 1.47, 11.7; P = 0.004). In contrast, sublobar resection was superior to lobar resection in terms of RFS (HR, 0.4; 95% CI, 0.22, 0.73; P = 0.002) for the negative-score group patients. For overall survival, lobar resection was favored in the positive-score group (P < 0.001), while sublobar resection was favored in the negative-score group (P < 0.04).
[CONCLUSIONS] The personalized surgical decision-making model potentially helps to decide the optimal surgical procedure for early-stage NSCLC.
MeSH Terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Female; Male; Neoplasm Staging; Middle Aged; Aged; Survival Rate; Follow-Up Studies; Clinical Decision-Making; Prognosis; Pneumonectomy; Precision Medicine; Propensity Score; Carcinoma, Squamous Cell; Retrospective Studies
같은 제1저자의 인용 많은 논문 (5)
- Targeting the IGF1/Twist1 axis: A novel mechanism for β-elemene-induced anoikis and EMT inhibition in breast cancer cells.
- Prognostic Value and Related Molecular Mechanisms of miR-5003-3p in Hepatocellular Carcinoma.
- ASO Visual Abstract: Personalized Surgical Decision-Making Model for Clinical Stage IA Pure-Solid Non-Small Cell Lung Cancer.
- Advances in Spatial Multi-Omics in Gastric Cancer.
- AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors.